# Regional Prophylactic Vancomycin With Restricted Tourniquet Time in Primary Total Knee Replacement

> **NCT03506347** · PHASE2,PHASE3 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 24 (actual)

## Conditions studied

- Arthropathy of Knee Joint

## Interventions

- **DRUG:** Vancomycin

## Key facts

- **NCT ID:** NCT03506347
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-24
- **Primary completion:** 2019-01-17
- **Final completion:** 2019-01-17
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2020-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03506347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03506347, "Regional Prophylactic Vancomycin With Restricted Tourniquet Time in Primary Total Knee Replacement". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03506347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*